22:57 , May 16, 2018 |  BC Extra  |  Company News

Management tracks: Novartis, Aileron

Novartis AG (NYSE:NVS; SIX:NOVN) said General Counsel Felix Ehrat will retire, effective June 1, in light of Novartis' payments to a consultancy owned by Michael Cohen. "As a co-signatory with our former CEO, I take...
00:30 , Oct 12, 2017 |  BC Innovations  |  Product R&D

Artificial mini proteins

Virvio Inc. has spun out of a group from the University of Washington to develop artificial mini proteins as novel influenza therapeutics. The mini proteins, typically ranging between 30 and 50 amino acids in length,...
22:43 , Jul 7, 2017 |  BioCentury  |  Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the continued...
20:20 , Jul 7, 2017 |  BC Week In Review  |  Financial News

Aileron raises $56.3M in IPO

On June 28, oncology play Aileron Therapeutics Inc. (NASDAQ:ALRN) raised $56.3 million through the sale of 3.8 million shares at $15 in an IPO underwritten by BofA Merrill Lynch, Jefferies, William Blair and Canaccord. Aileron Therapeutics...
22:43 , Jun 29, 2017 |  BC Extra  |  Financial News

Dova rises, Aileron sinks after NASDAQ listings

Rare disease company Dova Pharmaceuticals Inc. (NASDAQ:DOVA) and oncology play Aileron Therapeutics Inc. (NASDAQ:ALRN) each began trading Thursday after pricing IPOs. Dova gained $2.81 (17%) to $19.81 after raising $75.1 million through the sale of 4.4...
00:25 , Jun 21, 2017 |  BC Extra  |  Company News

Management tracks

Biogen Inc. (NASDAQ:BIIB) named Ginger Gregory EVP and chief human resources officer, effective July 17. She was chief human resources officer at Shire plc (LSE:SHP; NASDAQ:SHPG). Neurodegenerative, inflammation and cancer company Active Biotech AB (SSE:ACTI) promoted...
23:34 , Jun 15, 2017 |  BC Innovations  |  Tools & Techniques

Breaking the barrier

A three-way deal between Amgen Inc., Feldan Therapeutics Inc. and Elasmogen Ltd. is the latest cause for optimism that technologies are finally converging to enable the generation of cell-penetrating biologics. The biotechs join a small...
03:14 , Jun 9, 2017 |  BC Week In Review  |  Financial News

Aileron proposes $69M IPO

On June 2, stapled peptide therapeutics company Aileron Therapeutics Inc. (Cambridge, Mass.) proposed to raise $69 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch, Jefferies, William Blair and Canaccord. Aileron Therapeutics Inc., Cambridge,...
20:12 , Jun 5, 2017 |  BC Extra  |  Financial News

Dova, Aileron seek NASDAQ listings

Oncology play Aileron Therapeutics Inc. (Cambridge, Mass.) and rare disease company Dova Pharmaceuticals Inc. (Durham, N.C.) each proposed IPOs on NASDAQ. Stapled peptide therapeutic company Aileron filed to raise $69 million in an offering underwritten by...
23:34 , May 31, 2017 |  BC Innovations  |  Emerging Company Profile

Stapling β-catenin

Harvard University professor and serial entrepreneur Greg Verdine’s new start-up, FOG Pharmaceuticals Inc., is using his latest version of stapled peptide technology to block the notoriously undruggable protein, β-catenin, in metastatic colorectal cancer (mCRC). Stapled peptides...